424 EUR
3.1
0.74%
Last update Dec 16, 8:00 AM CET
Main market
Day range
424
424
Previous close
420.89999
Open
424
Access this stock data via API
Subscribe
United Therapeutics Corporation
424.00
3.10
0.74%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 681.4M 680.6M 677.0M 627.2M
Cost of revenue 86.0M 74.7M 78.8M 64.7M
Gross profit 595.4M 605.9M 598.2M 562.5M
Operating expense
Research & development 108.7M 114.2M 127.0M 114.0M
Selling general and admin 154.9M 162.6M 145.0M 138.5M
Other operating expenses
Operating income 331.8M 329.1M 326.2M 310.0M
Non operating interest income
Income 39.5M 43.7M 43.5M 42.0M
Expense 2.6M 6.2M 5.2M 6.7M
Other income expense 4.5M -18.6M -3.7M -7.3M
Pretax income 373.3M 348.1M 360.9M 337.9M
Tax provision 84.6M 84.3M 86.3M 81.1M
Net income 288.7M 263.8M 274.6M 256.8M
Basic EPS 6.9 7.2 6.7
Diluted EPS 6.4 6.6 6.2
Basic average shares 38.4M 38.3M 38.1M
Diluted average shares 41.2M 41.4M 41.5M
EBITDA 395.2M 390.8M 383.0M 366.6M
Net income from continuing op. 288.7M 263.8M 274.6M 256.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 47 minutes

12:12
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).